IMC Chicago
OCUL icon

IMC Chicago’s Ocular Therapeutix OCUL Stock Holding History

IMC Chicago’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$355K Buy
46,300
+29,600
+177% +$290K ﹤0.01% 5076
2026
Q2 		$164K Sell
16,700
-47,500
-74% -$431K ﹤0.01% 5792
2026
Q1 		$544K Buy
64,200
+33,700
+110% +$321K ﹤0.01% 3956
2025
Q4 		$370K Buy
+30,500
New +$370K ﹤0.01% 3674

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $135M AUM 15.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deltec Asset Management
Deltec Asset Management New York $642M AUM 16.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

IMC Chicago's OCUL Position: Q3 2026 in Review

IMC Chicago opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 756,372 shares worth $5.8M. The stake represents ﹤0.01% of the portfolio and ranks #2086 among its holdings. This is a return to the name: IMC Chicago previously reported a position in OCUL as recently as Q4 2025.

IMC Chicago first reported a position in OCUL in Q2 2025 and has held it in 3 quarters since. 142 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • IMC Chicago held 756,372 shares of Ocular Therapeutix worth $5.8M as of Q3 2026.
  • Ocular Therapeutix was a new IMC Chicago position in Q3 2026.
  • Ocular Therapeutix made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2086 holding.
  • IMC Chicago first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 3 quarters since.
  • 142 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.